Mast Cell-mediated Neuroinflammation
1 clinical trials · Condition
◉ Watch Mast Cell-mediated Neuroinflammation
| Record | Firm | Date |
|---|---|---|
| Topical Ketotifen 0.25% for Secondary Vestibulodynia (NCT07257029) | Center for Vulvovaginal Disorders | 2026-01-02 |
Track Mast Cell-mediated Neuroinflammation automatically
Every clearance here is in the API, with alerts when new ones post.